| 75.57 0.6 (0.8%) | 03-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 97.7 | 1-year : | 104.29 |
| Resists | First : | 83.65 | Second : | 89.29 |
| Pivot price | 79.4 |
|||
| Supports | First : | 74.52 | Second : | 62 |
| MAs | MA(5) : | 76.28 |
MA(20) : | 79.04 |
| MA(100) : | 74.95  |
MA(250) : | 71.2 |
|
| MACD | MACD : | -0.6 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 5.8 |
D(3) : | 6.9 |
| RSI | RSI(14): 40.8 |
|||
| 52-week | High : | 89.29 | Low : | 60.56 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ HSIC ] has closed above bottom band by 12.9%. Bollinger Bands are 42% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 75.96 - 76.33 | 76.33 - 76.65 |
| Low: | 73.81 - 74.24 | 74.24 - 74.61 |
| Close: | 74.93 - 75.59 | 75.59 - 76.16 |
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Fri, 13 Mar 2026
HSIC SEC Filings - Henry Schein, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Thu, 12 Mar 2026
Henry Schein: Still A Buy - But Caution Is Warranted (NASDAQ:HSIC) - Seeking Alpha
Thu, 12 Mar 2026
Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Thu, 12 Mar 2026
Insider Sell: Kurt Kuehn Sells Shares of Henry Schein Inc (HSIC) - GuruFocus
Tue, 10 Mar 2026
Henry Schein (HSIC) COO awarded 27,061 performance and restricted stock units - Stock Titan
Tue, 10 Mar 2026
How Investors May Respond To Henry Schein (HSIC) Earnings, Buybacks And New AI-Enabled Dentrix Ascend Packages - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 115 (M) |
| Shares Float | 95 (M) |
| Held by Insiders | 0.9 (%) |
| Held by Institutions | 106.5 (%) |
| Shares Short | 4,780 (K) |
| Shares Short P.Month | 5,110 (K) |
| EPS | 3.26 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.03 |
| Profit Margin | 3 % |
| Operating Margin | 5.3 % |
| Return on Assets (ttm) | 4.3 % |
| Return on Equity (ttm) | 8.6 % |
| Qtrly Rev. Growth | 7.6 % |
| Gross Profit (p.s.) | 35.74 |
| Sales Per Share | 114.9 |
| EBITDA (p.s.) | 8.89 |
| Qtrly Earnings Growth | 13.6 % |
| Operating Cash Flow | 712 (M) |
| Levered Free Cash Flow | 383 (M) |
| PE Ratio | 23.11 |
| PEG Ratio | 0 |
| Price to Book value | 2.69 |
| Price to Sales | 0.65 |
| Price to Cash Flow | 12.17 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|